BlueGnome Targets Cancer Cytogenetics Labs with Hematology Chip, New Format | GenomeWeb
BlueGnome, a seller of arrays and other consumables to the cytogenetic testing market, this week launched a hematology-themed array, the first in what the company said will become a new menu of next-generation chips.
Graham Snudden, co-founder and vice president of engineering of the Cambridge, UK-based firm, told BioArray News this week that the company has validated and begun shipping its hematology array for the investigation of the most common hematological malignancies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.